Le Lézard
Classified in: Health, Sports and recreation
Subjects: DIS, FVT

Quadriplegic Marc Buoniconti Set to Drive Dixie Vodka 400 Parade Laps in Adapted NASCAR Cup Series Car


FOUNTAIN, Colo., March 12, 2020 /PRNewswire/ -- NASCAR's March 22 Dixie Vodka 400 Cup Series race at Homestead-Miami Speedway will showcase the Falci Adaptive Motorsports vehicle piloted by The Miami Project's President and quadriplegic, Marc Buoniconti. The former Furniture Row NASCAR Cup car will participate in the ceremonial parade laps prior to the race's start. Paraplegic driver Rob "Chairslayer" Parsons will ride along to coach Buoniconti if needed.

The car's technology allows the passenger seat occupant to drive by braking and accelerating with the push and pull of their breath, while turning the vehicle is managed by the movement of their head. In the conventional driver's seat, a driver can drive with normal steering mechanisms or hand controls.

"This is a tremendous initiative being undertaken by Joe Garone and the Falci team," said Homestead-Miami Speedway President Al Garcia. "Through the outstanding efforts of Marc Buoniconti and his late father, Nick, the Miami Project to Cure Paralysis has done unbelievable work, not just here in Miami where it all started, but nationally and internationally as well. We are honored to host this landmark event during NASCAR's Dixie Vodka 400 race weekend and are excited to see the future of the adaptive vehicle and how it will benefit many people."

On the Thursday prior to Sunday's NASCAR Cup Series race, Falci Adaptive Motorsports and Pikes Peak International Raceway staff, led by current PPIR COO Joe Garone, will be onsite at Homestead-Miami Speedway executing another adaptive experience. The events give mobility challenged individuals the freedom to drive an 850-horsepower Cup car hands-and foot-free.

Thursday's event will be split into two portions. The first will provide guests a ride along experience at full speed with NASCAR driver Ross Chastain. In the second portion, Parsons will take the NASCAR driver's seat and coach the guests as they each take to the track and enjoy the freedom of driving for themselves.

"As anyone who knows me will attest, I have always been an avid race fan," said Buoniconti. "If it moves, especially if it moves fast, I want to watch it or be riding in it. When Falci Motorsports asked me to participate in this wonderful program, I naturally jumped at the chance to be a part of this event. Driving this adaptive car, particularly on my hometown track at Homestead-Miami Speedway, is a thrill of a lifetime. This demonstration will go a long way to prove to the world that adaptive driving and motorsports has the potential to be not only possible, but competitive."

Parsons will also be competing in this year's Pikes Peak International Hill Climb, the country's second-oldest automobile race next to the Indianapolis 500, also in an adaptive NASCAR Cup Series car.

In 2014, Dr. Scott Falci introduced the Falci adaptive technology to Furniture Row Racing, who agreed to help with his venture into NASCAR. Along with DireenTech, Dr. Falci continues to develop the adaptive technology in the vehicle to further aid the mobility challenged community. This includes working with Princeton University's engineering department to develop a brain interface that will allow the systems to be activated with thoughts alone.

The Dixie Vodka 400 will air live on FOX March 22 at 2 p.m. ET. Tickets for the Dixie Vodka 400 NASCAR weekend at Homestead-Miami Speedway are now available and can be purchased by calling (866) 409-RACE (7223) or visiting HomesteadMiamiSpeedway.com.

Media Contact 1: Chelsy Offutt
Director of Communications
Falci Adaptive Motorsports/Pikes Peak International Raceway
[email protected]
719.382.7223 x 119

Media Contact 2: Neal Gulkis
Senior Director, Communications & Marketing
Homestead-Miami Speedway
[email protected] 
o. 305.230.5233 | c. 305.224.3189

SOURCE Falci Adaptive Motorsports


These press releases may also interest you

at 21:45
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

at 21:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...



News published on and distributed by: